Green Alpha Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$467K	Buy	152,098 +1,020	+0.7%	+$3.94K	0.46%	61
2025 Q4	$618K	Sell	151,078 -61,124	-29%	-$303K	0.57%	56
2025 Q3	$1.04M	Buy	212,202 +37,109	+21%	+$195K	1%	33
2025 Q2	$886K	Sell	175,093 -3,780	-2%	-$18.6K	0.85%	38
2025 Q1	$946K	Buy	178,873 +111,728	+166%	+$815K	1.01%	28
2024 Q4	$454K	Buy	67,145 +2,346	+4%	+$15.8K	0.36%	95
2024 Q3	$427K	Buy	64,799 +1,800	+3%	+$12.9K	0.34%	96
2024 Q2	$472K	Sell	62,999 -9,435	-13%	-$82.3K	0.38%	93
2024 Q1	$722K	Buy	72,434 +4,563	+7%	+$50.8K	0.52%	75
2023 Q4	$669K	Buy	67,871 +33,329	+96%	+$238K	0.48%	85
2023 Q3	$264K	Buy	+34,542	New	+$345K	0.2%	131